EndoBarrier Gastrointestinal Liner: Additional pilot trial data

Additional data from an open-label pilot trial in 19 evaluable patients showed that EndoBarrier Gastrointestinal Liner reduced HbA1c and mean fasting plasma glucose (FPG) by 1.5% and 16.3 mg/dL, respe...